1-(4-(Trifluoromethoxy)phenyl)propan-1-amine hydrochloride, 98%, 100mg

3-(2-hydroxyethyl)-2-sulfanylidene-1,2,3,4-tetrahydroquinazolin-4-one, 97%, 250mg

(3S,9S,10R,13R,14R,17R)-10,13-Dimethyl-17-((R)-6-methylheptan-2-yl)-2,3,4,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol, 95%, 500g

(S)-2-((S)-2-Amino-3-phenylpropanamido)-3-(4-hydroxyphenyl)propanoic acid, 95.0%, 250mg

n-(Tert-butyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide, 98+%, 5g

3-(2,4-Difluorophenyl)-3-oxo-propionic acid ethyl ester, 95.0%, 2g

Propanoic acid, 2-[[4-[2-[[(cyclohexylamino)carbonyl](4-cyclohexylbutyl)amino]ethyl]phenyl]thio]-2-methyl-, 98%, 50mg

2-(3-Oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)acetic acid, 95.0%, 250mg

3-(Bromomethyl)-1,1-difluorocyclobutane, 95.0%, 250mg

1-METHYLCYCLOHEX-3-ENECARBOXYLIC ACID, 95.0%, 5g

1-BROMO-4-(ETHYLSULFONIMIDOYL)BENZENE, 95.0%, 100mg

N,N'-Dicarbobenzoxy-L-cystine>98.0%(T)1g

7-TRIDECANOL, 95%, 5g